HERG Screening Market

The global HERG Screening market is projected to reach $4,170.8 million by 2028, expanding at a compound annual growth rate (CAGR) of 13.29% from 2021 to 2028. This growth is driven by various macroeconomic and microeconomic factors, including the rising number of drug approvals, which significantly contribute to the demand for HERG screening.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Type (Mutant KCNH2, Gene KCNH2), By Ion Channel (Voltage Gated, Ligand Gated)
By Application (Antiarrhythmic, Antipsychotic, Antibiotics, Others)

Key players

Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
CREATIVE BIOARRAY
ABCAM PLC.
Aurora Biomed


Chapter 1. Executive Summary
Chapter 2. Scope of The Study
2.1. Market Definition
2.2. Scope of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on HERG Screening Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global HERG Screening Market, By Type
6.1. Introduction
6.2. Mutant KCNH2
6.3. Gene KCNH2
Chapter 7. Global HERG Screening Market, By Ion Channel
7.1. Introduction
7.2. Voltage Gated
7.3. Ligand Gated
Chapter 8. Global HERG Screening Market, By Application
8.1. Introduction
8.2. Antiarrhythmic
8.3. Antipsychotic
8.4. Antibiotics
8.5. Others
Chapter 9. Global HERG Screening Market, By Region
9.1. Introduction
9.2. North America
9.2.1. Introduction
9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.3. Market Size and Forecast, By Country, 2020 - 2028
9.2.4. Market Size and Forecast, By Type, 2020 - 2028
9.2.5. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.2.6. Market Size and Forecast, By Application, 2020 – 2028
9.2.7. US
9.2.7.1. Introduction
9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.7.3. Market Size and Forecast, By Type, 2020 - 2028
9.2.7.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.2.7.5. Market Size and Forecast, By Application, 2020 - 2028
9.2.8. Canada
9.2.8.1. Introduction
9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.8.4. Market Size and Forecast, By Type, 2020 - 2028
9.2.8.5. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.2.8.6. Market Size and Forecast, By Application, 2020 - 2028
9.3. Europe
9.3.1. Introduction
9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.3. Market Size and Forecast, By Country, 2020 - 2028
9.3.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.5. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.6. Market Size and Forecast, By Application, 2020 – 2028
9.3.7. Germany
9.3.7.1. Introduction
9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.7.3. Market Size and Forecast, By Type, 2020 - 2028
9.3.7.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.7.5. Market Size and Forecast, By Application, 2020 - 2028
9.3.8. France
9.3.8.1. Introduction
9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.8.3. Market Size and Forecast, By Type, 2020 - 2028
9.3.8.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.8.5. Market Size and Forecast, By Application, 2020 - 2028
9.3.9. UK
9.3.9.1. Introduction
9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.9.3. Market Size and Forecast, By Type, 2020 - 2028
9.3.9.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.9.5. Market Size and Forecast, By Application, 2020 - 2028
9.3.10. Italy
9.3.10.1. Introduction
9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.10.3. Market Size and Forecast, By Type, 2020 - 2028
9.3.10.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.10.5. Market Size and Forecast, By Application, 2020 - 2028
9.3.11. Rest of Europe
9.3.11.1. Introduction
9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.11.3. Market Size and Forecast, By Type, 2020 - 2028
9.3.11.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.3.11.5. Market Size and Forecast, By Application, 2020 - 2028
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.3. Market Size and Forecast, By Country, 2020 - 2028
9.4.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.5. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.7. Market Size and Forecast, By Application, 2020 - 2028
9.4.8. China
9.4.8.1. Introduction
9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.8.3. Market Size and Forecast, By Type, 2020 - 2028
9.4.8.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.8.5. Market Size and Forecast, By Application, 2020 - 2028
9.4.9. India
9.4.9.1. Introduction
9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.9.3. Market Size and Forecast, By Type, 2020 - 2028
9.4.9.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.9.5. Market Size and Forecast, By Application, 2020 - 2028
9.4.10. Japan
9.4.10.1. Introduction
9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.10.3. Market Size and Forecast, By Type, 2020 - 2028
9.4.10.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.10.5. Market Size and Forecast, By Application, 2020 - 2028
9.4.11. South Korea
9.4.11.1. Introduction
9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.11.3. Market Size and Forecast, By Type, 2020 - 2028
9.4.11.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.11.5. Market Size and Forecast, By Application, 2020 - 2028
9.4.12. Rest of Asia-Pacific
9.4.11.1. Introduction
9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.12.3. Market Size and Forecast, By Type, 2020 - 2028
9.4.12.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.4.12.5. Market Size and Forecast, By Application, 2020 - 2028
9.5. Rest of The World (RoW)
9.5.1. Introduction
9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.3. Market Size and Forecast, By Type, 2020 - 2028
9.5.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.5.5. Market Size and Forecast, By Application, 2020 - 2028
9.5.6. Market Size and Forecast, By Region, 2020 - 2028
9.5.7. South America
9.5.7.1. Introduction
9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.7.3. Market Size and Forecast, By Type, 2020 - 2028
9.5.7.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.5.7.5. Market Size and Forecast, By Application, 2020 - 2028
9.5.8. Middle East & Africa
9.5.8.1. Introduction
9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.8.3. Market Size and Forecast, By Type, 2020 - 2028
9.5.8.4. Market Size and Forecast, By Ion Channel, 2020 – 2028
9.5.8.5. Market Size and Forecast, By Application, 2020 - 2028
Chapter 10. Competitive Landscape
10.1. Introduction
10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
Chapter 11. Company Profiles
11.1. Charles River Laboratories
11.1.1. Business Overview
11.1.2. Financial Analysis
11.1.3. Product Portfolio
11.1.4. Recent Development and Strategies Adopted
11.1.5. SWOT Analysis
11.2. Eurofins Scientific
11.2.1. Business Overview
11.2.2. Financial Analysis
11.2.3. Product Portfolio
11.2.4. Recent Development and Strategies Adopted
11.2.5. SWOT Analysis
11.3. Merck KGaA
11.3.1. Business Overview
11.3.2. Financial Analysis
11.3.3. Product Portfolio
11.3.4. Recent Development and Strategies Adopted
11.3.5. SWOT Analysis
11.4. Cyprotex Limited
11.4.1. Business Overview
11.4.2. Financial Analysis
11.4.3. Product Portfolio
11.4.4. Recent Development and Strategies Adopted
11.4.5. SWOT Analysis
11.5. BSYS GmbH
11.5.1. Business Overview
11.5.2. Financial Analysis
11.5.3. Product Portfolio
11.5.4. Recent Development and Strategies Adopted
11.5.5. SWOT Analysis
11.6. Creative bioarray
11.6.1. Business Overview
11.6.2. Financial Analysis
11.6.3. Product Portfolio
11.6.4. Recent Development and Strategies Adopted
11.6.5. SWOT Analysis
11.7. Metrion biosciences
11.7.1. Business Overview
11.7.2. Financial Analysis
11.7.3. Product Portfolio
11.7.4. Recent Development and Strategies Adopted
11.7.5. SWOT Analysis
11.8. CREATIVE BIOARRAY
11.8.1. Business Overview
11.8.2. Financial Analysis
11.8.3. Product Portfolio
11.8.4. Recent Development and Strategies Adopted
11.8.5. SWOT Analysis
11.9. ABCAM PLC.
11.9.1. Business Overview
11.9.2. Financial Analysis
11.9.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
11.10. Aurora Biomed
11.10.1. Business Overview
11.10.2. Financial Analysis
11.10.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
Chapter 12. Key Takeaways

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings